Adviser Investments LLC Eli Lilly & CO Transaction History

Adviser Investments LLC

  • $7.95 Billion
  • Q3 2024

A detailed history of Adviser Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Adviser Investments LLC holds 44,163 shares of LLY stock, worth $34.4 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
44,163
Previous 45,482 2.9%
Holding current value
$34.4 Million
Previous $41.2 Million 4.99%
% of portfolio
0.49%
Previous 0.55%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$772.14 - $960.02 $1.02 Million - $1.27 Million
-1,319 Reduced 2.9%
44,163 $39.1 Million
Q2 2024

Aug 12, 2024
SELL
$724.87 - $909.04 $565,398 - $709,051
-780 Reduced 1.69%
45,482 $41.2 Million
Q1 2024

Apr 29, 2024
SELL
$592.2 - $792.28 $7.59 Million - $10.2 Million
-12,815 Reduced 21.69%
46,262 $36 Million
Q4 2023

Feb 01, 2024
BUY
$525.19 - $619.13 $19.1 Million - $22.5 Million
36,293 Added 159.29%
59,077 $34.4 Million
Q3 2023

Oct 11, 2023
BUY
$434.7 - $599.3 $659,439 - $909,138
1,517 Added 7.13%
22,784 $12.2 Million
Q2 2023

Aug 04, 2023
BUY
$350.74 - $468.98 $528,565 - $706,752
1,507 Added 7.63%
21,267 $9.97 Million
Q1 2023

Apr 25, 2023
BUY
$310.63 - $364.82 $5.69 Million - $6.68 Million
18,317 Added 1269.37%
19,760 $6.79 Million
Q4 2022

Jan 19, 2023
SELL
$321.55 - $374.67 $7,074 - $8,242
-22 Reduced 1.5%
1,443 $0
Q2 2022

Jul 14, 2022
BUY
$278.73 - $327.27 $44,318 - $52,035
159 Added 12.17%
1,465 $475,000
Q1 2022

May 04, 2022
BUY
$234.69 - $291.66 $104,437 - $129,788
445 Added 51.68%
1,306 $374,000
Q4 2021

Jan 31, 2022
BUY
$224.85 - $279.04 $193,595 - $240,253
861 New
861 $238,000
Q2 2021

Jul 09, 2021
SELL
$180.55 - $233.54 $198,785 - $257,127
-1,101 Closed
0 $0
Q1 2021

May 05, 2021
BUY
$164.32 - $212.72 $180,916 - $234,204
1,101 New
1,101 $206,000
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $527,854 - $610,559
-3,610 Closed
0 $0
Q2 2020

Aug 03, 2020
BUY
$136.42 - $164.18 $492,476 - $592,689
3,610 New
3,610 $593,000
Q3 2018

Nov 14, 2018
SELL
$85.86 - $107.31 $85,860 - $107,310
-1,000 Closed
0 $0
Q2 2018

Aug 02, 2018
BUY
$75.7 - $86.88 $75,700 - $86,880
1,000 New
1,000 $85,000
Q1 2018

May 14, 2018
SELL
$74.21 - $87.6 $207,045 - $244,403
-2,790 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
2,790
2,790 $230,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Adviser Investments LLC Portfolio

Follow Adviser Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email